DANIEL HERING: Open Payments
NPI 1518203512 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 17 payments from 9 companies in 2025. Trend: 2023 $1,293 · 2024 $1,334 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $326 |
| AstraZeneca Pharmaceuticals LP | 4 | $141 |
| Electromed, Inc. | 2 | $135 |
| Mylan Inc. | 1 | $127 |
| Actelion Pharmaceuticals US, Inc. | 2 | $125 |
| Verona Pharma, Inc. | 2 | $62 |
| Baxter Healthcare | 1 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: DUPIXENT, SMARTVEST, YUPELRI, UPTRAVI, BREZTRI, Ohtuvayre, Hillrom - Monarch Airway Clearance System, AIRSUPRA.
Industry payments across NV — which companies pay providers there.
